147 related articles for article (PubMed ID: 17118497)
1. Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.
Martino A; Casetti R; Poccia F
Vaccine; 2007 Jan; 25(6):1023-9. PubMed ID: 17118497
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response.
Dieli F; Caccamo N; Meraviglia S; Ivanyi J; Sireci G; Bonanno CT; Ferlazzo V; La Mendola C; Salerno A
Eur J Immunol; 2004 Nov; 34(11):3227-35. PubMed ID: 15376192
[TBL] [Abstract][Full Text] [Related]
3. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.
Gagliardi MC; Teloni R; Giannoni F; Pardini M; Sargentini V; Brunori L; Fattorini L; Nisini R
J Leukoc Biol; 2005 Jul; 78(1):106-13. PubMed ID: 15845642
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.
Tsukaguchi K; de Lange B; Boom WH
Cell Immunol; 1999 May; 194(1):12-20. PubMed ID: 10357876
[TBL] [Abstract][Full Text] [Related]
7. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
[TBL] [Abstract][Full Text] [Related]
8. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
[TBL] [Abstract][Full Text] [Related]
10. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
11. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M
J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
Devilder MC; Maillet S; Bouyge-Moreau I; Donnadieu E; Bonneville M; Scotet E
J Immunol; 2006 Feb; 176(3):1386-93. PubMed ID: 16424165
[TBL] [Abstract][Full Text] [Related]
13. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
[TBL] [Abstract][Full Text] [Related]
14. Impaired maturation and function of dendritic cells by mycobacteria through IL-1beta.
Makino M; Maeda Y; Mukai T; Kaufmann SH
Eur J Immunol; 2006 Jun; 36(6):1443-52. PubMed ID: 16673446
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice.
Morel C; Badell E; Abadie V; Robledo M; Setterblad N; Gluckman JC; Gicquel B; Boudaly S; Winter N
Eur J Immunol; 2008 Feb; 38(2):437-47. PubMed ID: 18203135
[TBL] [Abstract][Full Text] [Related]
16. Human gammadelta T cells modulate the mite allergen-specific T-helper type 2-skewed immunity.
Korematsu S; Tanaka Y; Nagakura T; Minato N; Izumi T
Clin Exp Allergy; 2007 Nov; 37(11):1681-7. PubMed ID: 17883427
[TBL] [Abstract][Full Text] [Related]
17. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
18. Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
Cabillic F; Toutirais O; Lavoué V; de La Pintière CT; Daniel P; Rioux-Leclerc N; Turlin B; Mönkkönen H; Mönkkönen J; Boudjema K; Catros V; Bouet-Toussaint F
Cancer Immunol Immunother; 2010 Nov; 59(11):1611-9. PubMed ID: 20582413
[TBL] [Abstract][Full Text] [Related]
19. Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6.
Frick JS; Zahir N; Müller M; Kahl F; Bechtold O; Lutz MB; Kirschning CJ; Reimann J; Jilge B; Bohn E; Autenrieth IB
Eur J Immunol; 2006 Jun; 36(6):1537-47. PubMed ID: 16708404
[TBL] [Abstract][Full Text] [Related]
20. A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth.
Higuchi T; Shimizu M; Owaki A; Takahashi M; Shinya E; Nishimura T; Takahashi H
Cancer Immunol Immunother; 2009 Aug; 58(8):1245-55. PubMed ID: 19139883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
